BioCardia, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
BioCardia, Inc. (BCDA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $47.97 per share as of 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2025-03-26
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $47.97.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $3.51.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.04.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $5.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2024-12-31 | $47.97 10-K · filed 2025-03-26 |
| 2023-12-31 | $3.51 10-K · filed 2024-03-27 |
| 2022-12-31 | $4.04 10-K · filed 2023-03-29 |
| 2021-12-31 | $5.00 10-K · filed 2022-03-29 |
| 2020-12-31 | $5.89 10-K · filed 2021-03-30 |
| 2016-12-31 | $0.15 10-K · filed 2017-03-30 |
| 2016-09-30 | $0.23 10-Q · filed 2016-10-17 |
| 2016-06-30 | $0.23 10-Q · filed 2016-08-02 |
| 2016-03-31 | $0.23 10-Q · filed 2016-05-03 |
| 2015-12-31 | $0.23 10-K · filed 2016-03-25 |
| 2015-09-30 | $0.23 10-Q · filed 2015-10-29 |
| 2015-03-31 | $0.23 10-Q · filed 2015-05-12 |
| 2014-12-31 | $0.23 10-Q · filed 2015-08-12 |
| 2014-09-30 | $0.23 10-Q · filed 2014-11-06 |
| 2014-06-30 | $0.23 10-Q · filed 2014-08-06 |
| 2014-03-31 | $0.23 10-Q · filed 2014-05-12 |
| 2012-12-31 | $0.23 10-K · filed 2014-03-24 |
| 2012-09-30 | $0.23 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.23 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |